Shionogi & Co, headquartered in Osaka, Japan, has agreed to acquire IntraBio, a biopharmaceutical company developing and ...

Beam Therapeutics has appointed Eric Foster as Chief Commercial Officer (CCO). Foster will lead Beam’s commercial ...

The new global awareness initiative calls for greater recognition, understanding and support for people living with chronic ...

MSD, known as Merck in the US and Canada, has announced the first presentation of results from MK-7240-012, a phase 2b ...

Roche’s fenebrutinib has received FDA filing acceptance under priority review for a New Drug Application (NDA) for relapsing ...

Inizio Evoke has appointed Jake Vander Linden as President, Media, where he leads media strategy, planning, activation, ...

Global healthcare communications consultancy ANTHEM, a Resonant Group company, today announces the launch of Healthy ...

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of ...

Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes ...

Inizio Evoke has appointed Brian Gundich in the newly created role of EVP, AI Enablement, a role that reflects the agency’s ...

Healthcare has always been complex, but the pace of change feels greater than ever. Innovation is accelerating, AI is ...

Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in ...